Ashley P Kennedy1, David H Epstein1, Michelle L Jobes1, Daniel Agage2, Matthew Tyburski2, Karran A Phillips1, Amin Ahsan Ali3, Rummana Bari3, Syed Monowar Hossain3, Karen Hovsepian4, Md Mahbubur Rahman3, Emre Ertin5, Santosh Kumar3, Kenzie L Preston6. 1. Clinical Pharmacology and Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, United States. 2. Johns Hopkins Bayview Medical Center, Baltimore, MD, United States. 3. Department of Computer Science, University of Memphis, Memphis, TN, United States. 4. Department of Computer Science, Troy University, Troy, AL, United States. 5. Department of Electrical & Computer Engineering, The Ohio State University, Columbus, OH, United States. 6. Clinical Pharmacology and Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, United States. Electronic address: kpreston@intra.nida.nih.gov.
Abstract
BACKGROUND: Ambulatory physiological monitoring could clarify antecedents and consequences of drug use and could contribute to a sensor-triggered mobile intervention that automatically detects behaviorally risky situations. Our goal was to show that such monitoring is feasible and can produce meaningful data. METHODS: We assessed heart rate (HR) with AutoSense, a suite of biosensors that wirelessly transmits data to a smartphone, for up to 4 weeks in 40 polydrug users in opioid-agonist maintenance as they went about their daily lives. Participants also self-reported drug use, mood, and activities on electronic diaries. We compared HR with self-report using multilevel modeling (SAS Proc Mixed). RESULTS: Compliance with AutoSense was good; the data yield from the wireless electrocardiographs was 85.7%. HR was higher when participants reported cocaine use than when they reported heroin use (F(2,9)=250.3, p<.0001) and was also higher as a function of the dose of cocaine reported (F(1,8)=207.7, p<.0001). HR was higher when participants reported craving heroin (F(1,16)=230.9, p<.0001) or cocaine (F(1,14)=157.2, p<.0001) than when they reported of not craving. HR was lower (p<.05) in randomly prompted entries in which participants reported feeling relaxed, feeling happy, or watching TV, and was higher when they reported feeling stressed, being hassled, or walking. CONCLUSIONS: High-yield, high-quality heart-rate data can be obtained from drug users in their natural environment as they go about their daily lives, and the resultant data robustly reflect episodes of cocaine and heroin use and other mental and behavioral events of interest. Published by Elsevier Ireland Ltd.
BACKGROUND: Ambulatory physiological monitoring could clarify antecedents and consequences of drug use and could contribute to a sensor-triggered mobile intervention that automatically detects behaviorally risky situations. Our goal was to show that such monitoring is feasible and can produce meaningful data. METHODS: We assessed heart rate (HR) with AutoSense, a suite of biosensors that wirelessly transmits data to a smartphone, for up to 4 weeks in 40 polydrug users in opioid-agonist maintenance as they went about their daily lives. Participants also self-reported drug use, mood, and activities on electronic diaries. We compared HR with self-report using multilevel modeling (SAS Proc Mixed). RESULTS: Compliance with AutoSense was good; the data yield from the wireless electrocardiographs was 85.7%. HR was higher when participants reported cocaine use than when they reported heroin use (F(2,9)=250.3, p<.0001) and was also higher as a function of the dose of cocaine reported (F(1,8)=207.7, p<.0001). HR was higher when participants reported craving heroin (F(1,16)=230.9, p<.0001) or cocaine (F(1,14)=157.2, p<.0001) than when they reported of not craving. HR was lower (p<.05) in randomly prompted entries in which participants reported feeling relaxed, feeling happy, or watching TV, and was higher when they reported feeling stressed, being hassled, or walking. CONCLUSIONS: High-yield, high-quality heart-rate data can be obtained from drug users in their natural environment as they go about their daily lives, and the resultant data robustly reflect episodes of cocaine and heroin use and other mental and behavioral events of interest. Published by Elsevier Ireland Ltd.
Authors: Andrew J Waters; Edwin H Szeto; David W Wetter; Paul M Cinciripini; Jason D Robinson; Yisheng Li Journal: Nicotine Tob Res Date: 2013-07-30 Impact factor: 4.244
Authors: David H Epstein; Matthew Tyburski; Ian M Craig; Karran A Phillips; Michelle L Jobes; Massoud Vahabzadeh; Mustapha Mezghanni; Jia-Ling Lin; C Debra M Furr-Holden; Kenzie L Preston Journal: Drug Alcohol Depend Date: 2013-09-14 Impact factor: 4.492
Authors: Kenzie L Preston; Massoud Vahabzadeh; John Schmittner; Jia-Ling Lin; David A Gorelick; David H Epstein Journal: Psychopharmacology (Berl) Date: 2009-09-24 Impact factor: 4.530
Authors: Melody Furnari; David H Epstein; Karran A Phillips; Michelle L Jobes; William J Kowalczyk; Massoud Vahabzadeh; Jia-Ling Lin; Kenzie L Preston Journal: Psychopharmacology (Berl) Date: 2015-07-09 Impact factor: 4.530
Authors: Suppawong Tuarob; Conrad S Tucker; Soundar Kumara; C Lee Giles; Aaron L Pincus; David E Conroy; Nilam Ram Journal: J Biomed Inform Date: 2017-02-15 Impact factor: 6.317
Authors: Kenzie L Preston; William J Kowalczyk; Karran A Phillips; Michelle L Jobes; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein Journal: Psychopharmacology (Berl) Date: 2017-06-08 Impact factor: 4.530
Authors: Samuel W Stull; Jeremiah W Bertz; Leigh V Panlilio; William J Kowalczyk; Karran A Phillips; Landhing M Moran; Jia-Ling Lin; Massoud Vahabzadeh; Patrick H Finan; Kenzie L Preston; David H Epstein Journal: J Abnorm Psychol Date: 2021-07
Authors: Lisa A Marsch; Aimee Campbell; Cynthia Campbell; Ching-Hua Chen; Emre Ertin; Udi Ghitza; Chantal Lambert-Harris; Saeed Hassanpour; August F Holtyn; Yih-Ing Hser; Petra Jacobs; Jeffrey D Klausner; Shea Lemley; David Kotz; Andrea Meier; Bethany McLeman; Jennifer McNeely; Varun Mishra; Larissa Mooney; Edward Nunes; Chrysovalantis Stafylis; Catherine Stanger; Elizabeth Saunders; Geetha Subramaniam; Sean Young Journal: J Subst Abuse Treat Date: 2020-03
Authors: Kenzie L Preston; William J Kowalczyk; Karran A Phillips; Michelle L Jobes; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein Journal: Neuropsychopharmacology Date: 2017-11-06 Impact factor: 7.853
Authors: Emre Ertin; Nithin Sugavanam; August F Holtyn; Kenzie L Preston; Jeremiah W Bertz; Lisa A Marsch; Bethany McLeman; Dikla Shmueli-Blumberg; Julia Collins; Jacqueline S King; Jennifer McCormack; Udi E Ghitza Journal: Front Psychiatry Date: 2021-06-24 Impact factor: 4.157